3.95
                                            전일 마감가:
              $3.90
            열려 있는:
              $3.85
            하루 거래량:
                246.95K
            Relative Volume:
              0.71
            시가총액:
                $213.12M
            수익:
              $2.76M
            순이익/손실:
              $-49.12M
            주가수익비율:
              -2.6333
            EPS:
                -1.5
            순현금흐름:
                $-46.21M
            1주 성능:
              +0.00%
            1개월 성능:
              +45.76%
            6개월 성능:
                +44.16%
            1년 성능:
              -25.33%
            Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
명칭
                  
                      Orchestra Biomed Holdings Inc
                    
                전화
                  
                      646-343-9298
                    
                주소
                  
                      150 UNION SQUARE DRIVE, NEW HOPE
                    
                OBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                OBIO
                            
                             
                        Orchestra Biomed Holdings Inc 
                           | 
                    3.95 | 210.42M | 2.76M | -49.12M | -46.21M | -1.50 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 | 
|---|---|---|---|
| 2025-08-20 | 다운그레이드 | BTIG Research | Buy → Neutral | 
| 2025-03-20 | 개시 | BTIG Research | Buy | 
| 2025-01-02 | 개시 | Barclays | Overweight | 
| 2024-08-22 | 개시 | H.C. Wainwright | Buy | 
| 2024-07-25 | 개시 | B. Riley Securities | Buy | 
| 2024-01-19 | 개시 | Jefferies | Buy | 
| 2023-02-24 | 개시 | Piper Sandler | Overweight | 
| 2023-02-07 | 개시 | Chardan Capital Markets | Buy | 
                    모두보기
                    
                  
                Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
Is Orchestra BioMed Holdings Inc. reversing from oversold territoryVolume Spike & AI Driven Stock Reports - newser.com
Can Orchestra BioMed Holdings Inc. stock withstand economic slowdown2025 Market Sentiment & Breakout Confirmation Alerts - newser.com
How sentiment analysis helps forecast Orchestra BioMed Holdings Inc.July 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
Orchestra BioMed (Nasdaq: OBIO) Nov. 12 call on Medtronic collaboration, pivotal trials - Stock Titan
How to use a screener to detect Orchestra BioMed Holdings Inc. breakouts2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com
Is Orchestra BioMed Holdings Inc. stock supported by strong cash flowsPortfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Is this a good reentry point in Orchestra BioMed Holdings Inc.Earnings Risk Report & Advanced Technical Signal Analysis - newser.com
Can Orchestra BioMed Holdings Inc. stock reach $100 price targetWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Orchestra BioMed Holdings Inc. stock outperform tech sector in 2025Portfolio Return Report & Fast Gain Swing Trade Alerts - newser.com
Will Orchestra BioMed Holdings Inc. stock recover after recent drop2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - newser.com
What to expect from Orchestra BioMed Holdings Inc. in the next 30 daysInsider Buying & Weekly Market Pulse Alerts - newser.com
The past five years for Orchestra BioMed Holdings (NASDAQ:OBIO) investors has not been profitable - Yahoo Finance
Q3 Earnings Forecast for Orchestra BioMed Issued By B. Riley - MarketBeat
Will Orchestra BioMed Holdings Inc. stock beat EPS estimatesChart Signals & Safe Entry Momentum Tips - newser.com
Exit strategy if you’re trapped in Orchestra BioMed Holdings Inc.Gap Down & Weekly Watchlist for Hot Stocks - newser.com
Custom watchlist performance reports with Orchestra BioMed Holdings Inc.2025 Top Gainers & Stepwise Trade Signal Implementation - newser.com
How currency fluctuations impact Orchestra BioMed Holdings Inc. stock2025 Investor Takeaways & Weekly Top Gainers Alerts - newser.com
Certain Stock Options of Orchestra BioMed Holdings, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2025. - MarketScreener
Certain Pre-Funded Warrants of Orchestra BioMed Holdings, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2025. - MarketScreener
Certain Common Stock of Orchestra BioMed Holdings, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2025. - MarketScreener
Orchestra BioMed Holdings, Inc. Announces Strategic Developments and Financial Milestones - TradingView
What drives Orchestra BioMed Holdings Inc stock priceMarket Depth Overview & Small Capital Portfolio Tips - earlytimes.in
Orchestra BioMed Announces First Patients Enrolled in Virtue SAB US Pivotal IDE Coronary Trial - HMP Global Learning Network
Orchestra Biomed Holdings Inc (OBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
                자본화:
                 
                  | 
                볼륨(24시간):